• About us
• Contact

Advertisement

Organisation › Details

Euronext Brussels

Euronext is the primary exchange in the Euro zone with more than 1 300 issuers worth €3.1 trillion in market capitalisation, an unmatched blue-chip franchise consisting of 24 issuers in the EURO STOXX 50® benchmark and a strong, diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets. Its total product offering includes Equities, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. Euronext operates regulated markets, Alternext and the Free Market; in addition it offers EnterNext, which facilitates SMEs’ access to capital markets. *

 

	Start	2002-12-11 existent
	Group	Euronext (Group)
	Industry	financial services
	Person	van Dessel, Vincent (Euronext 201511 CEO of Euronext Brussels)
	Region	Brussels
	Country	Belgium
	Street	Place de la Bourse/Beursplein Palais de la Bourse/Bourspaleis
	City	1000 Brussels
	Tel	+32-2-509-1211
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2024-02-12

Advertisement

More documents for Euronext (Group)

• [1] Carbios S.A.. (7/11/23). "Press Release: Carbios Announces the Success of Its Capital Increase with Preferential Subscription Rights of Approximately 141 Million Euros, the Largest on Euronext Growth since 2015". Clermont-Ferrand....
• [2] Carbios S.A.. (6/22/23). "Press Release: Carbios Announces the Launch of a Rights Issue Totalling around €122 Million, Likely to Be Increased to around €141 Million if the Extension Clause Is Fully Exercised". Clermont-Ferrand....
• [3] BenevolentAI. (4/25/22). "Press Release: BenevolentAI Begins Trading On Euronext Amsterdam". London....
• [4] Euronext N.V.. (4/25/22). "Press Release: BenevolentAI Lists on Euronext Amsterdam. Listed Following Business Combination with Odyssey Acquisition S.A.". Amsterdam....
• [5] Aelis Farma S.A.. (2/15/22). "Press Release: Aelis Farma, a Biopharmaceutical Company Developing a New Generation of Drugs for Brain Diseases, Announces the Success of Its Initial Public Offering and Raises approximately €25 Million on Euronext Paris [N...
• [6] Euronext N.V.. (11/18/21). "Press Release: European Healthcare Acquisition & Growth Company B.V (EHC) Lists on Euronext Amsterdam". Amsterdam....
• [7] Euronext N.V.. (11/2/21). "Press Release: Acticor Biotech Lists on Euronext Growth Paris". Paris....
• [8] MaaT Pharma. (10/15/21). "Press Release: MaaT Pharma Launches Its Initial Public Offering on the Regulated Market of Euronext in Paris [ Not for US, CA, AU, JP or RK ]". Lyon....
• [9] Afyren SAS. (8/26/21). "Press Release: Afyren, the Innovative Greentech for Sustainable Chemistry, Announces Its Planned IPO on Euronext Growth® in Paris [Not for US, CA, et al.]". Clermont-Ferrand....
• [10] NFL Biosciences S.A.. (6/30/21). "Press Release: NFL Biosciences Raises €5.0M, Following Its Successful Initial Public Offering on Euronext Growth Partis [Not for United States of America, the United Kingdom, Canada, Australia or Japan]". Montpellier....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.